Scientist Home Future Health Limited (NASDAQ: SHFH) is a health supplements and topical creams company that develops and sells proprietary wellness products from Hong Kong. Revenue comes from direct product sales of six health supplements and topical creams targeting bone, joint, vascular, and digestive health. The company was incorporated on July 3, 2024 and operates out of Kwun Tong, Kowloon, Hong Kong. For the year ended December 31, 2025, the company reported an operating loss of $231,725 and net cash used in operating activities of $248,278. The auditor issued a going concern qualification as of the December 31, 2025 balance sheet date, citing dependence on shareholder support and external financing to meet obligations. CEO and founder Chan Siu Hung holds 84.33% of common stock as of the filing date. No competitors are named in the filing excerpts.

Revenue model

Transactional product sales of health supplements and topical creams sold directly to consumers. The company initially offered six primary products. No subscription, licensing, or royalty revenue streams are disclosed in the filing.

Products and services

Six primary products as of the 10-K filed 2026-03-27: (1) Scientist Home Vein Cream, a topical cream; (2) a bone and joint health supplement containing mixed gelatine hydrolysate, mineral complex, vitamin complex, cetylated fatty acids, rosehips, taurine, and luo han fruit; (3) Scientist Home High Concentration Proteinase, a digestive enzyme supplement containing bromelain, plant protease concentrate, and related proteolytic enzymes. Full details on the remaining three products are not fully reproduced in the filing excerpts. The company discloses that no scientific evidence supports product health claims.

Customers and end markets

Health-conscious individuals seeking natural wellness solutions, individuals seeking preventative health care or relief from chronic conditions, elderly populations managing arthritis, joint stiffness, and cardiovascular concerns, and professionals and athletes with muscle strain or soreness. Customer counts are not disclosed in the filing.

Value-chain role

Product developer and seller of proprietary branded health supplements and topical creams. The company is responsible for ensuring products meet Hong Kong food safety regulations including the Food Adulteration (Metallic Contamination) Regulations and the Food and Drugs (Composition and Labelling) Regulation 2008. Manufacturing sourcing is not described in the filing excerpts.

Geographic exposure

Operations primarily in Hong Kong, with a registered address at Room B3, Block B, 3/F, Mow Hing Industrial Building, 205 Wai Yip Street, Kwun Tong, Kowloon, Hong Kong. No other geographic markets are disclosed.

Source: SEC 10-K, filed 2026-03-27

Industry: Perfumes, Cosmetics & Other Toilet Preparations